ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
The global average price of ELISA is in the decreasing trend, from 211 USD /Unit in 2011 to 196 USD/ Unit in 2015. with the situation of global economy, prices will be in decreasing trend in the following five years.
the classification of ELISA includes ELISA Sets ELISA Kits, and the proportion of ELISA Kits in 2015 is about 61%.ELISA is widely used in IVD testing field.
USA is the largest supplier of ELISA, with a production market share nearly 48% in 2015. Europe is the second largest supplier of ELISA, enjoying production market share nearly 34% in 2015.
North america is the largest consumption place, with a consumption market share nearly 40% in 2015. following north america, europe is the second largest consumption place with the consumption market share of 26%. China is the world's largest import country.
market competition is not intense. R&D Systems and Thermo Fisher Scientific, are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Enzyme-Linked Immunosorbent Assay (ELISA) market will register a 3.5% CAGR in terms of revenue, the global market size will reach US$ 200 million by 2024, from US$ 160 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Enzyme-Linked Immunosorbent Assay (ELISA) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzyme-Linked Immunosorbent Assay (ELISA) market by product type, application, key manufacturers and key regions and countries.
This study considers the Enzyme-Linked Immunosorbent Assay (ELISA) value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
ELISA Sets
ELISA Kits
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
ELISA in HIV
ELISA in West Nile Virus
Detecting Antigens or Antibodies
Biodefense
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Shenzhen YHLO Biotech
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Enzyme-Linked Immunosorbent Assay (ELISA) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Enzyme-Linked Immunosorbent Assay (ELISA) market by identifying its various subsegments.
Focuses on the key global Enzyme-Linked Immunosorbent Assay (ELISA) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Enzyme-Linked Immunosorbent Assay (ELISA) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Enzyme-Linked Immunosorbent Assay (ELISA) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Summary:
Get latest Market Research Reports on Enzyme-Linked Immunosorbent Assay (ELISA) . Industry analysis & Market Report on Enzyme-Linked Immunosorbent Assay (ELISA) is a syndicated market report, published as Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Enzyme-Linked Immunosorbent Assay (ELISA) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.